Radiation-before-pathology approach in the palliative oncology setting: a pragmatic clinical trial protocol (RT-NOW)
Sympascho Young(Western University), David A. Palma(Western University), Matthew J. Cecchini(Western University), Timothy K. Nguyen(Western University), Christopher D. Goodman(London Health Sciences Centre), Joanna Laba(London Health Sciences Centre), Andrew Warner(London Health Sciences Centre), Glenn Bauman(Thomas Jefferson University Hospital), Xiaotao Qu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Melissa O’Neil(Western University)
Cited by 0
Related Papers
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
|The Lancet|2019|1.9k
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
|The Lancet Oncology|2017|1.8k
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
|Journal of Clinical Oncology|2020|1.3k